PAK1 and breast carcinoma: Furthermore, it was shown recently that combination of PAK1 inhibitor (FRAX1036) with taxane treatment could induce microtubule disorganisation, cell cycle arrests and cellular apoptosis in the luminal subtype of breast cancer.10